-
Something wrong with this record ?
Immunostimulatory properties and antitumor activities of glucans (Review)
L. Vannucci, J. Krizan, P. Sima, D. Stakheev, F. Caja, L. Rajsiglova, V. Horak, M. Saieh,
Language English Country Greece
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
NLK
Free Medical Journals
from 2006 to 1 year ago
ProQuest Central
from 2012-01-01
Nursing & Allied Health Database (ProQuest)
from 2012-01-01
Health & Medicine (ProQuest)
from 2012-01-01
PubMed
23739801
DOI
10.3892/ijo.2013.1974
Knihovny.cz E-resources
- MeSH
- Adjuvants, Immunologic chemistry therapeutic use MeSH
- Agaricales chemistry MeSH
- beta-Glucans chemistry therapeutic use MeSH
- Cell Extracts therapeutic use MeSH
- Dendritic Cells drug effects MeSH
- Lectins, C-Type metabolism MeSH
- Humans MeSH
- Macrophages drug effects immunology MeSH
- Mice MeSH
- Immunity, Innate drug effects MeSH
- Antineoplastic Agents chemistry immunology therapeutic use MeSH
- Signal Transduction immunology MeSH
- Medicine, East Asian Traditional MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
New foods and natural biological modulators have recently become of scientific interest in the investigation of the value of traditional medical therapeutics. Glucans have an important part in this renewed interest. These fungal wall components are claimed to be useful for various medical purposes and they are obtained from medicinal mushrooms commonly used in traditional Oriental medicine. The immunotherapeutic properties of fungi extracts have been reported, including the enhancement of anticancer immunity responses. These properties are principally related to the stimulation of cells of the innate immune system. The discovery of specific receptors for glucans on dendritic cells (dectin-1), as well as interactions with other receptors, mainly expressed by innate immune cells (e.g., Toll-like receptors, complement receptor-3), have raised new attention toward these products as suitable therapeutic agents. We briefly review the characteristics of the glucans from mycelial walls as modulators of the immunity and their possible use as antitumor treatments.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14051019
- 003
- CZ-PrNML
- 005
- 20140410102218.0
- 007
- ta
- 008
- 140401s2013 gr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3892/ijo.2013.1974 $2 doi
- 035 __
- $a (PubMed)23739801
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Vannucci, Luca
- 245 10
- $a Immunostimulatory properties and antitumor activities of glucans (Review) / $c L. Vannucci, J. Krizan, P. Sima, D. Stakheev, F. Caja, L. Rajsiglova, V. Horak, M. Saieh,
- 520 9_
- $a New foods and natural biological modulators have recently become of scientific interest in the investigation of the value of traditional medical therapeutics. Glucans have an important part in this renewed interest. These fungal wall components are claimed to be useful for various medical purposes and they are obtained from medicinal mushrooms commonly used in traditional Oriental medicine. The immunotherapeutic properties of fungi extracts have been reported, including the enhancement of anticancer immunity responses. These properties are principally related to the stimulation of cells of the innate immune system. The discovery of specific receptors for glucans on dendritic cells (dectin-1), as well as interactions with other receptors, mainly expressed by innate immune cells (e.g., Toll-like receptors, complement receptor-3), have raised new attention toward these products as suitable therapeutic agents. We briefly review the characteristics of the glucans from mycelial walls as modulators of the immunity and their possible use as antitumor treatments.
- 650 _2
- $a adjuvancia imunologická $x chemie $x terapeutické užití $7 D000276
- 650 _2
- $a Agaricales $x chemie $7 D000363
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a protinádorové látky $x chemie $x imunologie $x terapeutické užití $7 D000970
- 650 _2
- $a buněčné extrakty $x terapeutické užití $7 D002457
- 650 _2
- $a dendritické buňky $x účinky léků $7 D003713
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a přirozená imunita $x účinky léků $7 D007113
- 650 _2
- $a lektiny typu C $x metabolismus $7 D037181
- 650 _2
- $a makrofágy $x účinky léků $x imunologie $7 D008264
- 650 _2
- $a tradiční orientální medicína $7 D008518
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a signální transdukce $x imunologie $7 D015398
- 650 _2
- $a beta-glukany $x chemie $x terapeutické užití $7 D047071
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Krizan, Jiri $u -
- 700 1_
- $a Sima, Petr $u -
- 700 1_
- $a Stakheev, Dmitry $u -
- 700 1_
- $a Caja, Fabian $u -
- 700 1_
- $a Rajsiglova, Lenka $u -
- 700 1_
- $a Horak, Vratislav $u -
- 700 1_
- $a Saieh, Mustafa $u -
- 773 0_
- $w MED00002350 $t International journal of oncology $x 1791-2423 $g Roč. 43, č. 2 (2013), s. 357-64
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23739801 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140401 $b ABA008
- 991 __
- $a 20140410102308 $b ABA008
- 999 __
- $a ok $b bmc $g 1018155 $s 849599
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 43 $c 2 $d 357-64 $i 1791-2423 $m International journal of oncology $n Int J Oncol $x MED00002350
- LZP __
- $a Pubmed-20140401